271 filings
Page 7 of 14
UPLOAD
tclmcu9t kg7
10 Jan 18
Letter from SEC
12:00am
CORRESP
rmfojwoap8
3 Jan 18
Correspondence with SEC
12:00am
8-K
7r6t4d72a szyc1
29 Dec 17
Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System
12:00am
UPLOAD
9b3mgur13h2
18 Dec 17
Letter from SEC
12:00am
8-K
2ge2w4
20 Nov 17
Regulation FD Disclosure
12:00am
8-K
r4ya9jjkv
14 Nov 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
NT 10-Q
96t58 sbq
14 Nov 17
Notice of late quarterly filing
12:00am
8-K
rl35umefsk45phmsrqwb
19 Oct 17
Submission of Matters to a Vote of Security Holders
12:00am
UPLOAD
5oclduxi jdhr
8 Sep 17
Letter from SEC
12:00am
8-K
u6i4zuiz2c5eas bc
29 Aug 17
Medovex Corporation Receives Regulatory Approval from Australia's Therapeutic Goods Administration (TGA) for its DenerveX System
12:00am
8-K
45kqkt8pp
21 Aug 17
Medovex Corporation Names Charlie Farrahar Chief Financial Officer
12:00am
8-K
56mmq 8mecg1
9 Aug 17
Regulation FD Disclosure
12:00am